In silico, in vitro, and in vivo assessment of chitosan-diltiazem nanoparticles against pulmonary fibrosis
These findings indicate the strong therapeutic potential of DIL-TMC for IPF with minimal cardiovascular side effects.
Authors
- Vishal S. Patil (ORCID: https://orcid.org/0000-0002-1219-1962)
- Chandrakantsing V. Pardeshi (ORCID: https://orcid.org/0000-0001-7264-0603)
- Niharika Patil
- Chandragouda R. Patil (ORCID: https://orcid.org/0000-0001-8401-1978)
- Nandeeni Punase
- Ghanshyam Mapare
- Ganesh V. Jamdar
- Narendra R. Nagpure (ORCID: https://orcid.org/0009-0003-8399-7618)
Institutions
- Shri Vile Parle Kelavani Mandal (IN)
Publication Details
- Journal
- Therapeutic Delivery
- Published
- 2025-03-24
- DOI
- https://doi.org/10.1080/20415990.2025.2478803
- Primary Topic
- Inhalation and Respiratory Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00